Abstract:The fat-mass and obesity-associated (FTO) protein employs an iron(IV) oxo species to demethylate N-methylated nucleic acids. Herein, we use atomistic-theoretical calculations to study the demethylation of the N-methylated DNA/RNA bases 6-methylated adenine (m(6)A), 3-methylated thymine (m(3)T), and 3-methylated uracil (m(3)U). The mechanisms involve in-enzyme hydroxylation of the methyl group, followed by hydrolysis of the oxidized intermediates in aqueous solution to demethylate the bases. The in-enzyme reactions have been studied using quantum mechanical/molecular mechanical (QM/MM) calculations, while the hydrolytic reactions occurring outside the enzyme have been explored with hybrid cluster-continuum (HCC) calculations. When the results obtained with these different methods are combined, the calculated barrier for the overall transformation is consistent with the experimental free energy barrier for the major route of m(6)A demethylation: in this pathway, adenine's N1 site acts as an internal base catalyst in the rate-determining hydrolysis of the hydroxylated hemiaminal intermediate hm(6)A to a demethylated A and formaldehyde. This N1-catalyzed mechanism makes m(6)A the most reactive substrate in comparison to other bases we tested. In the minor, slower, route, two oxidation steps by FTO generate an amide intermediate (f(6)A) that undergoes in-water hydrolysis, producing A and formic acid, as found experimentally. In contrast, since m(3)T and m(3)U lack internal basic catalytic sites, their hemiaminals decompose with high barriers. The mechanism instead involves two sequential oxidations, leading to demethylated bases and formic acid. Thus, our results, obtained using a holistic approach combining modeling the enzyme and the surrounding aqueous solution, suggest revisions of the experimental mechanisms for m(3)T and m(3)U demethylation.

Structural Insights into FTO's Catalytic Mechanism for the Demethylation of Multiple RNA Substrates

Structural insights into FTO’s catalytic mechanism for the demethylation of multiple RNA substrates

Differential M(6)a, M(6)a(m), and M(1)a Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm

Differential m6A, m6Am, and m1A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm.

Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor.

Preparation of Human Nuclear RNA m⁶A Methyltransferases and Demethylases and Biochemical Characterization of Their Catalytic Activity.

The dynamics of FTO binding and demethylation from the m 6 A motifs.

Mechanism and Function of Oxidative Reversal of DNA and RNA Methylation

Identification of Specific N 6 -Methyladenosine RNA Demethylase FTO Inhibitors by Single-Quantum-Dot-Based FRET Nanosensors

Computations Reveal a Rich Mechanistic Variation of Demethylation of N-Methylated DNA/RNA Nucleotides by FTO

Demethylase FTO activity analysis based on methyl sensitive enzyme MazF and hybridization chain reaction

Enzymatic Characterization of In Vitro Activity of RNA Methyltransferase PCIF1 on DNA

Identification of Specific N6-Methyladenosine RNA Demethylase FTO Inhibitors by Single-Quantum-Dot-Based FRET Nanosensors.

Crystal Structures of the Human RNA Demethylase Alkbh5 Reveal Basis for Substrate Recognition.

A Demethylation-Switchable Aptamer Design Enables Lag-Free Monitoring of M6a Demethylase FTO with Energy Self-Sufficient and Structurally Integrated Features.

A Strategy Based on Nucleotide Specificity Leads to a Subfamily-Selective and Cell-Active Inhibitor of N6-methyladenosine Demethylase FTO.

Identification of Flavin Mononucleotide As a Cell‐Active Artificial N6‐Methyladenosine RNA Demethylase

RNA Demethylation-Driven Functional Supramolecular Structure for Label-Free Detection of M6a Modification Eraser FTO in Human Breast Tissues

Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5

Insights into the m6A demethylases FTO and ALKBH5 : structural, biological function, and inhibitor development

Construction of a N6-Methyladenosine Demethylation-Switched Deoxyribozyme Circuit for in Vitro and in Situ Detection of FTO Activity